Danaher Corporation Q1 2026 Earnings Call Summary
Danaher Corporation reported strong Q1 2026 results driven by bioprocessing demand and Life Sciences performance, despite a lighter respiratory season at Cepheid. The company raised full-year adjusted EPS guidance to $8.35 to $8.55 and highlighted the pending Masimo acquisition as a strategic growth opportunity.
Topics: Earnings M&A Market Outlook Operational Efficiency Revenue Growth